National Academies Press: OpenBook
« Previous: Appendix B: Disclosure of Unavoidable Conflict of Interest
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

C

Open Session Agendas

September 22, 2020
CLOSED SESSION
Full Schedule in Eastern Time

11:00–11:15 Welcome
GUY PALMER, Committee Chair
11:15–12:45 Bias and Conflict of Interest Discussion
LAUREN SHERN, Director of Policy, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine
12:45–1:00 Review Statement of Task and Study Timeline
GUY PALMER, Committee Chair
1:00–1:30 Framing the Report for Policy Makers
JULIE EUBANK, Assistant Director, Congressional and Government Affairs, National Academies of Sciences, Engineering, and Medicine
1:30 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

September 23, 2020
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:10 Welcome
GUY PALMER, Committee Chair
11:10–11:50 Sponsor Orientation to Statement of Task
JANE KNISELY, Program Officer, Bacteriology and Mycology Branch, National Institute of Allergy and Infectious Diseases (NIAID)
11:50–12:15 ASPE Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
AMANDA CASH, Director, Division of Evidence, Evaluation, and Data Policy, Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services
12:15–12:40 USDA Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
NEENA ANADARAMAN, Veterinary Science Policy Advisor, Office of the Chief Scientist, U.S. Department of Agriculture (USDA)
12:40–1:05 NIH Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
JANE KNISELY, Program Officer, Bacteriology and Mycology Branch, NIAID
1:05–1:30 BARDA Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
MARK ALBRECHT, Branch Chief, Anti-Bacterial Program, Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)
1:30 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

September 24, 2020
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:30 USAID Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
JESSICA PETRILLO, Senior Advisor for Antimicrobial Resistance and GHSA, Emerging Threats Division, Office of Infectious Diseases, Bureau for Global Health, U.S. Agency for International Development
11:30–11:55 FDA Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
WILLIAM FLYNN, Deputy Director for Science Policy, Center for Veterinary Medicine, Food and Drug Administration (FDA)
11:55–12:20 CDC Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
MICHAEL CRAIG, Senior Advisor for Antibiotic Resistance, Antibiotic Resistance Coordination and Strategy Unit, Centers for Disease Control and Prevention
12:20–12:45 Department of Defense Involvement on the National Strategy for Combating Antimicrobial-Resistant Bacteria
PAIGE WATERMAN, CARB Task Force Lead, Walter Reed Army Institute of Research, Department of Defense
12:45–1:30 Q&A
1:30 Adjourn

September 25, 2020
CLOSED SESSION
Full Schedule in Eastern Time

11:00–1:30 Closed session for committee deliberations.
1:30 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

November 9, 2020
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:35 Additional Federal Actions Needed to Determine Magnitude and Reduce Impact of Antibiotic Resistance
TIMOTHY PERSONS, Chief Scientist and Managing Director, Science, Technology Assessment, and Analytics, Government Accountability Office
MARY DENIGAN-MACAULEY, Director, Health Care, Public Health & Private Markets, Government Accountability Office
11:35–12:05 Convergence in Antimicrobial Use and Factor Influencing Resistance
RAMANAN LAXMINARAYAN, Director and Senior Fellow, Center for Disease Dynamics, Economics & Policy
12:05–12:15 Break
12:15–12:45 Measuring the Impacts of FDA’s Actions to Promote Judicious Antimicrobial Use in Veterinary Medicine
SUSAN BRIGHT, Veterinary Medical Officer, Office of Surveillance & Compliance, Center for Veterinary Medicine, FDA
12:45–1:15 National Scale Monitoring of Antimicrobial Resistance in Surface Water
JAY GARLAND, Senior Research Scientist, Office of Research and Development, Environmental Protection Agency
1:15–1:45 International Activities in AMR, Department of Health and Human Services
LYNN FILPI, AMR Team Lead, Senior Global Health Officer, Pandemic and Emerging Threat Office, Office of Global Affairs, HHS
1:45–2:00 Closing Questions
2:00 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

November 10, 2020
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:35 Monitoring Countries’ Progress on Tripartite Global Action Plan
ANAND BALACHANDRAN, Unit Head, AMR National Action Plans and Monitoring & Evaluation, AMR Division, World Health Organization (WHO) Headquarters
11:35–12:05 The Norwegian National Strategy Against Antibiotic Resistance
GUNNAR SKOV SIMONSEN, Professor of Clinical Microbiology, University of Tromsø; Director of the Department of Microbiology and Infection Control, University Hospital of North Norway
12:05–12:15 Break
12:15–12:45 Antibiotic Resistance in the Food Chain
FRANK MØLLER AARESTRUP, Professor, Head of Division, Division for Global Surveillance, Research Group for Genomic Epidemiology, National Food Institute, Technical University of Denmark
12:45–1:15 Antimicrobial Use in Companion Animals
MARK PAPICH, Professor of Clinical Pharmacology, Burroughs Wellcome Fund Professorship in Veterinary Pharmacology, College of Veterinary Medicine, North Carolina State University
1:15–1:45 Antimicrobial Use in Chilean Aquaculture
FELIPE C. CABELLO, Professor Emeritus, Department of Microbiology and Immunology, New York Medical College
1:45–2:00 Closing Questions
2:00 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

November 11, 2020
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:05 Welcome
Guy Palmer, Committee Chair
11:05–11:35 The Global Antibiotic-Resistance Surveillance System
CARMEM L PESSOA-SILVA, Unit Head—Surveillance, Evidence and Laboratory Strengthening, AMR Division, WHO
11:35–12:05 Shaping Strategies for Prevention and Response to Antibiotic Resistance
TIM JINKS, Head Drug-Resistant Infections Priority Program, Wellcome Trust
12:05–12:15 Break
12:15–12:45 The Fleming Fund Support for AMR Surveillance
TOM PILCHER, Head of Country Coordination, The Fleming Fund, Department of Health and Social Care
CLAIRE GORDON, Lead Clinical Microbiologist, Mott MacDonald/The Fleming Fund
12:45–1:15 The Bill & Melinda Gates Foundation’s Strategy in AMR
PADMINI SRIKANTIAH, Senior Program Officer, Global Health Antimicrobial Resistance Strategy Lead, Bill & Melinda Gates Foundation
1:45–2:00 Questions and Discussion
2:00 Adjourn

November 13, 2020
CLOSED SESSION
Full Schedule in Eastern Time

11:00–12:30 Debrief on Presentations
GUY PALMER, Committee Chair
12:30–1:30 Next Steps
GUY PALMER, Committee Chair
1:30 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

January 5, 2021
OPEN SESSION
The Antimicrobial Product Pipeline and Incentives for Market Viability
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:30 The Post-Approval Challenges of Antimicrobial Development
KEVIN KRAUSE, Vice President, Clinical Science and Development Operations, AN2 Therapeutics Inc.
11:30–11:55 Pricing of Antibiotics and Proposals to Strengthen the Pipeline
JOHN REX, Chief Medical Officer and Director, F2G, Ltd.; Editor-in-Chief, AMR Solutions; Operating Partner, Advent Life Sciences
12:00–12:15 Break
12:15–1:45 Panel Discussion on Push and Pull Incentives
LEFTERIS MYLONAKIS, Moderator
WES KIM, Senior Officer, Antibiotic Resistance Project, The Pew Charitable Trusts
KEVIN OUTTERSON, Executive Director, Combating Antibiotic-Bacteria Biopharmaceutical Accelerator
RYAN CIRZ, CSO and Acting Chief Executive Officer, Revagenix, Inc.
MARK ALBRECHT, Branch Chief, Anti-Bacterial Program, Division of CBRN Countermeasures, BARDA
1:45–2:10 Championing Patient and Public Health Needs: IDSA Efforts to Strengthen the Antibiotic Pipeline
HELEN BOUCHER, Chief, Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center
Director, Levy Center for Integrated Management of Antimicrobial Resistance
Treasurer, Infectious Diseases Society of America
2:10–2:35 A New, Sustainable Model for Antibiotic R&D
BRAD SPELLBERG, Chief Medical Officer, Los Angeles County-University of Southern California Medical Center
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
2:45 Adjourn

January 6, 2021
OPEN SESSION
Diagnostics and Susceptibility Testing
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:30 The Relationship Between Antimicrobial Susceptibility Testing Devices and Antibiotic Markets
KEVIN KRAUSE, Vice President, Clinical Science and Development Operations, AN2 Therapeutics Inc.
11:30–11:55 Regulatory Challenges in Antimicrobial Diagnostics
BARBARA ZIMMER, Principal Scientist, Microbiology Scientific Affairs, Beckman Coulter, Inc.
11:55–1:15 Diagnostics Panel Discussion
JENN DIEN BARD, Moderator
MARK MILLER, Chief Medical Officer, bioMerieux
FRED C. TENOVER, Vice President, Scientific Affairs, Cepheid
ANGELA CALIENDO, Warren Alpert Foundation Professor of Medicine, Executive Vice Chair of Medicine, Alpert Medical School, Brown University
BARBARA ZIMMER, Principal Scientist, Microbiology Scientific Affairs, Beckman Coulter, Inc.
1:15–1:30 Break
1:30–1:50 VetCAST Susceptibility Test Breakpoints
PETER PANDURO DAMBORG, Associate Professor, Veterinary Clinical Microbiology, University of Copenhagen
1:50–2:10 Addressing Challenges in Veterinary Diagnostics
BRIAN LUBBERS, Associate Professor, College of Veterinary Medicine, Kansas State University
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
2:10–2:45 Discussion on Veterinary Diagnostics and Susceptibility Test Breakpoints
EMMANUEL OKELLO, Moderator
PETER PANDURO DAMBORG, Associate Professor, Veterinary
Clinical Microbiology, University of Copenhagen
BRIAN LUBBERS, Associate Professor, College of Veterinary Medicine, Kansas State University
2:45 Adjourn

January 7, 2021
OPEN SESSION
Antimicrobial Stewardship
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:30 Telehealth and Antimicrobial Stewardship
JOHN LYNCH, Associate Medical Director, Harborview Medical Center Antimicrobial Stewardship Program; Associate Professor, Division of Allergy and Infectious Diseases, University of Washington School of Medicine
11:30–11:55 Antimicrobial Stewardship in Remote Areas
MARC MENDELSON, Professor of Infectious Disease, Division of Infectious Diseases & HIV Medicine, University of Cape Town
11:55–12:20 Antimicrobial Stewardship in Nursing Homes: Barriers and Opportunities
CHRIS CRNICH, Chief of Medicine, Madison VA Hospital; Associate Professor of Medicine, Division of Infectious Diseases, University of Wisconsin School of Medicine and Public Health
12:20–12:35 Break
12:35–1:00 The Road to Research and Development of Alternatives to Antibiotics in the United States
CYRIL GAY, Senior National Program Leader, Animal Production and Protection, Agricultural Research Service, USDA
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
1:00–2:30 Panel Discussion on Incentives for Stewardship in Agribusiness
MARTA GOMEZ-CHIARRI, Moderator
BRUCE STEWART-BROWN, Senior Vice-President of Food Safety, Quality, and Live Operations, Perdue Foods
BILL KELEHER, President and Chief Executive Officer, Kennebec River Biosciences
CRAIG WILSON, Vice President, GMM, Costco Wholesale
HEATHER FOWLER, Director of Producer and Public Health, National Pork Board
2:30 Adjourn

January 8, 2021
OPEN SESSION
Full Schedule in Eastern Time

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:35 Anthropology of Antimicrobial Resistance
CLARE CHANDLER, Professor in Medical Anthropology; Director, London School of Hygiene & Tropical Medicine
11:35–12:05 The Global Burden of Antimicrobial Resistance
CHRIS MURRAY, Director, Institute for Health Metrics and Evaluation; Chair and Professor, Health Metrics Sciences, University of Washington
12:05 Open Session Adjourn

CLOSED SESSION
Full Schedule in Eastern Time

12:05–12:20 Break
12:20–1:20 Debrief
GUY PALMER, Committee Chair
1:20–2:00 Next Steps
GUY PALMER, Committee Chair
2:00 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

March 16, 2021
OPEN SESSION

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:35 GARDP and Antimicrobial Development
MANICA BALASEGARAM, Executive Director, Global Antibiotic R&D Partnership
JENNIFER SCHNEIDER, Senior Advisor External Affairs, Global Antibiotic R&D Partnership
11:35–12:05 Inpatient Reimbursement and the Antimicrobial Market
ANAND SHAH, former Deputy Commissioner for Medical and Scientific Affairs, FDA
12:05 Adjourn Open Session

March 16, 2021
CLOSED SESSION

12:15–12:30 Overview Draft Recommendations, Guidance on Writing Recommendations
12:30–3:00 Discussion of Draft Recommendations and Conclusions in Stewardship and Prevention
3:00 Adjourn

March 17, 2021
CLOSED SESSION

11:00–12:00 Discussion of Draft Recommendations and Conclusions on Push and Pull Incentives
12:00–12:15 Break
12:15–2:45 Discussion of Draft Recommendations and Conclusions on Diagnostics and Related Questions
2:45 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

March 18, 2021
CLOSED SESSION

11:00–12:00 Discussion of Draft Recommendations and Conclusions on International Action
12:00–12:15 Break
12:15–2:00 Discussion Draft Recommendations and Conclusions on Health and Economic Burden
2:00 Adjourn

March 19, 2021
OPEN SESSION

11:00–11:05 Welcome
GUY PALMER, Committee Chair
11:05–11:45 Direct, Predictive Application of Sequencing and Informatics
GAUTAM DANTAS, Professor, Washington University School of Medicine
11:45 Adjourn Open Session

March 19, 2021
CLOSED SESSION

12:00–1:00 Discussion of Draft Recommendations and Conclusions on Surveillance
1:00 Adjourn

May 11, 2021
CLOSED SESSION

11:00–2:00 Deliberation on Report Recommendations
2:00 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

May 12, 2021
CLOSED SESSION

11:00–12:15 Deliberation on Report Recommendations
12:15–12:30 Break

May 12, 2021
OPEN SESSION

12:30–1:30 Agencies’ Progress on National Action Plan, Mixed Methods Analysis
KRIS MOORE, Medical Director, Center for Infectious Disease Research and Policy, University of Minnesota
1:30 End Open Session

May 12, 2021
CLOSED SESSION

1:30 Debrief on Presentation
2:00 Adjourn

May 13, 2021
CLOSED SESSION

11:00–2:00 Deliberation on Report Recommendations
2:00 Adjourn

May 14, 2021
CLOSED SESSION

11:00–2:00 Deliberation on Report Recommendations
2:00 Adjourn
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×

This page intentionally left blank.

Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 353
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 354
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 355
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 356
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 357
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 358
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 359
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 360
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 361
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 362
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 363
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 364
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 365
Suggested Citation:"Appendix C: Open Session Agendas." National Academies of Sciences, Engineering, and Medicine. 2022. Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine. Washington, DC: The National Academies Press. doi: 10.17226/26350.
×
Page 366
Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine Get This Book
×
Buy Paperback | $45.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Antimicrobial resistance is a health problem that threatens to undermine almost a century of medical progress. Moreover, it is a global problem that requires action both in the United States and internationally.

Combating Antimicrobial Resistance and Protecting the Miracle of Modern Medicine discusses ways to improve detection of resistant infections in the United States and abroad, including monitoring environmental reservoirs of resistance. This report sets out a strategy for improving stewardship and preventing infections in humans and animals. The report also discusses the strength of the pipeline for new antimicrobial medicines and steps that could be taken to bring a range of preventive and therapeutic products for humans and animals to the market.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!